Source: ORPHANET

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0001815
Disease: Primary Myelofibrosis
Primary Myelofibrosis 		0.500 SomaticCausalMutation ORPHANET TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. 19262601

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0001815
Disease: Primary Myelofibrosis
Primary Myelofibrosis 		0.500 SomaticCausalMutation ORPHANET TET2 mutations in myelodysplasia and myeloid malignancies. 19557078

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C1264195
Disease: Refractory anemia with ringed sideroblasts
Refractory anemia with ringed sideroblasts 		0.420 SomaticCausalMutation ORPHANET TET2 mutations in myelodysplasia and myeloid malignancies. 19557078

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C1264195
Disease: Refractory anemia with ringed sideroblasts
Refractory anemia with ringed sideroblasts 		0.420 SomaticCausalMutation ORPHANET Acquired mutations in TET2 are common in myelodysplastic syndromes. 19483684

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0032463
Disease: Polycythemia Vera
Polycythemia Vera 		0.400 SomaticCausalMutation ORPHANET TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. 19262601

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0040028
Disease: Thrombocythemia, Essential
Thrombocythemia, Essential 		0.360 Biomarker ORPHANET TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings. 23781511

2013
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0040028
Disease: Thrombocythemia, Essential
Thrombocythemia, Essential 		0.360 Biomarker ORPHANET TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. 19262601

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0026987
Disease: Myelofibrosis
Myelofibrosis 		0.340 SomaticCausalMutation ORPHANET TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. 19262601

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0026987
Disease: Myelofibrosis
Myelofibrosis 		0.340 SomaticCausalMutation ORPHANET TET2 mutations in myelodysplasia and myeloid malignancies. 19557078

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0002893
Disease: Refractory anemias
Refractory anemias 		0.310 SomaticCausalMutation ORPHANET Acquired mutations in TET2 are common in myelodysplastic syndromes. 19483684

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0002893
Disease: Refractory anemias
Refractory anemias 		0.310 SomaticCausalMutation ORPHANET TET2 mutations in myelodysplasia and myeloid malignancies. 19557078

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C1301365
Disease: Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease
Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease 		0.300 SomaticCausalMutation ORPHANET Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. 25567135

2015
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0002894
Disease: Refractory anaemia with excess blasts
Refractory anaemia with excess blasts 		0.300 SomaticCausalMutation ORPHANET Acquired mutations in TET2 are common in myelodysplastic syndromes. 19483684

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C0002894
Disease: Refractory anaemia with excess blasts
Refractory anaemia with excess blasts 		0.300 SomaticCausalMutation ORPHANET TET2 mutations in myelodysplasia and myeloid malignancies. 19557078

2009
Entrez Id: 54790
Gene Symbol: TET2
TET2
CUI: C1292773
Disease: Acute myeloid leukemia with multilineage dysplasia
Acute myeloid leukemia with multilineage dysplasia 		0.300 SomaticCausalMutation ORPHANET TET2 mutations in myelodysplasia and myeloid malignancies. 19557078

2009